Patents by Inventor INTERCEPT PHARMACEUTICALS, INC.

INTERCEPT PHARMACEUTICALS, INC. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TGR5 Modulators and Methods of Use Thereof
    Publication number: 20140100209
    Abstract: The invention relates to compounds of Formula A: or a salt, solvate, hydrate, or prodrug thereof. The compounds of Formula A are TGR5 modulators useful for the treatment of various diseases, including metabolic disease, inflammatory disease, liver disease, autoimmune disease, cardiac disease, kidney disease, cancer, and gastrointestinal disease.
    Type: Application
    Filed: April 26, 2013
    Publication date: April 10, 2014
    Applicant: INTERCEPT PHARMACEUTICALS, INC.
    Inventor: Intercept Pharmaceuticals, Inc.
  • TGR5 Modulators and Methods of Use Thereof
    Publication number: 20140094443
    Abstract: The invention relates to compounds of Formula A: or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof. The compounds of Formula A are TGR5 modulators useful for the treatment of various diseases, including obesity, insulin sensitivity, inflammation, cholestasis, and bile desaturation.
    Type: Application
    Filed: April 1, 2013
    Publication date: April 3, 2014
    Applicant: INTERCEPT PHARMACEUTICALS, INC.
    Inventor: Intercept Pharmaceuticals, Inc.
  • Steroids as Agonists for FXR
    Publication number: 20140024631
    Abstract: The invention relates to compounds of formula (I): wherein R is ethyl, propyl or allyl, and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof. The compounds of formula (I) are useful as FXR agonists.
    Type: Application
    Filed: February 7, 2013
    Publication date: January 23, 2014
    Applicant: INTERCEPT PHARMACEUTICALS, INC.
    Inventor: INTERCEPT PHARMACEUTICALS, INC.